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Dairy Foods, Calcium, and Colorectal Cancer: A Pooled
Analysis of 10 Cohort Studies
Eunyoung Cho, Stephanie A. Smith-Warner, Donna Spiegelman, W. Lawrence
Beeson, Piet A. van den Brandt, Graham A. Colditz, Aaron R. Folsom,
Gary E. Fraser, Jo L. Freudenheim, Edward Giovannucci, R. Alexandra
Goldbohm, Saxon Graham, Anthony B. Miller, Pirjo Pietinen, John D. Potter,
Thomas E. Rohan, Paul Terry, Paolo Toniolo, Mikko J. Virtanen,
Walter C. Willett, Alicja Wolk, Kana Wu, Shiaw-Shyuan Yaun,
Anne Zeleniuch-Jacquotte, David J. Hunter
Background: Studies in animals have suggested that calcium
may reduce the risk of colorectal cancer. However, results
from epidemiologic studies of intake of calcium or dairy
foods and colorectal cancer risk have been inconclusive.
Methods: We pooled the primary data from 10 cohort studies
in five countries that assessed usual dietary intake by using
a validated food frequency questionnaire at baseline. For
most studies, follow-up was extended beyond that in the
original publication. The studies included 534 536 individu-
als, among whom 4992 incident cases of colorectal cancer
were diagnosed between 6 and 16 years of follow-up. Pooled
multivariable relative risks for categories of milk intake and
quintiles of calcium intake and 95% confidence intervals
(CIs) were calculated. All statistical tests were two-sided.
Results: Milk intake was related to a reduced risk of colo-
rectal cancer. Compared with the lowest category of intake
(<70 g/day), relative risks of colorectal cancer for increasing
categories (70–174, 175–249, and >250 g/day) of milk intake
were 0.94 (95% CI  0.86 to 1.02), 0.88 (95% CI  0.81 to
0.96), and 0.85 (95% CI  0.78 to 0.94), respectively
(Ptrend<.001). Calcium intake was also inversely related to
the risk of colorectal cancer. The relative risk for the highest
versus the lowest quintile of intake was 0.86 (95% CI  0.78
to 0.95; Ptrend  .02) for dietary calcium and 0.78 (95% CI
 0.69 to 0.88; Ptrend<.001) for total calcium (combining
dietary and supplemental sources). These results were con-
sistent across studies and sex. The inverse association for
milk was limited to cancers of the distal colon (Ptrend<.001)
and rectum (Ptrend  .02). Conclusion: Higher consumption
of milk and calcium is associated with a lower risk of colo-
rectal cancer. [J Natl Cancer Inst 2004;96:1015–22]
Colorectal cancer is the third most common incident cancer
worldwide (1), and international differences in incidence have
been hypothesized to be related to diet (2). Evidence from
animal studies has suggested that high calcium intake may
reduce colonic carcinogenesis (3). In humans, calcium supple-
ments have been shown to reduce colonic epithelial cell prolif-
eration (4) and risk of recurrent colorectal adenomas (5), and
low-fat dairy foods reduce proliferation and normalize differen-
tiation of colonic epithelial cells (6).
Results from epidemiologic studies of consumption of dairy
foods and calcium and colorectal cancer risk have been incon-
clusive, with most studies reporting weak, statistically nonsig-
nificant inverse associations (7–10), perhaps reflecting limited
sample sizes. In this study, we examined the associations be-
tween the consumption of dairy foods and calcium and colorec-
tal cancer risk in a pooled analysis of 10 cohort studies from
North America and Europe. Most of the individual studies
included in our analysis have published results of intakes of
calcium (11–18) and dairy foods (11,12,14,16,18–20) on colo-
rectal cancer risk. For most of these studies, follow-up was
extended in the current analysis relative to the time of follow-up
in the original published results.
METHODS
Population
The Pooling Project of Prospective Studies of Diet and Can-
cer has been described elsewhere (21,22). For the colorectal
cancer analyses, we identified 10 prospective studies (11–13,
16–18,20,23,24) that met the following predefined criteria: at
least 50 people diagnosed with incident colorectal cancer; as-
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sessment of long-term dietary intake; and validation of either the
dietary assessment method itself or a closely related instrument.
Because most studies included only one sex, studies that in-
cluded women and men were analyzed as two separate cohorts.
The person-time experienced during follow-up of the Nurses’
Health Study (17) was divided into two segments to take advan-
tage of the more detailed dietary assessment completed in 1986.
On the basis of the underlying theory of survival data, blocks of
person-time in different time periods are asymptotically uncor-
related, regardless of the extent to which they are derived from
the same people (25).
Exclusion Criteria
For the primary data from each study, we applied the exclu-
sion criteria used by that study (11–13,16–18,20,23,24), and
then we further excluded participants if they had loge-
transformed energy intakes beyond three standard deviations
from the study-specific loge-transformed mean energy intake of
the population. We also further excluded participants if they
reported a history of cancer other than nonmelanoma skin cancer
at baseline.
Case Definition
In each study, incident colorectal cancers were ascertained by
self-report with subsequent medical record review (17), linkage
with a cancer registry (11–13,18,23,24), or both (16,20). In some
studies (13,16–18,23,24), additional linkage with a death regis-
try was used.
Dietary Assessment
The baseline food frequency questionnaire for each study
inquired about typical consumption of food items, generally over
the past year. The number of questions on dairy foods on the
food frequency questionnaires ranged from one in the New York
State Cohort (24) to 20 in the Alpha-Tocopherol Beta-Carotene
Cancer Prevention Study (16). We examined associations be-
tween colorectal cancer risk and three groups of dairy foods
(milk, cheese, and yogurt) because these groups were measured
in most of the studies. Other dairy foods that were measured in
at least half of the studies were examined separately.
Studies provided data for the intake of calcium from food
only (dietary calcium) and from food and supplements (total
calcium), if available. Because the amount of calcium in multi-
vitamins was not estimated in the Adventist Health Study (20)
and in the New York State Cohort (24), we used the calcium
values for generic multivitamins (130 mg/day) in the Nurses’
Health Study food frequency questionnaire database to derive
total calcium intakes for these studies. The correlations for
dietary calcium between intakes estimated by the food frequency
questionnaire and either multiple diet records or 24-hour recalls
ranged from 0.48 to 0.70 (26–29) (A. Wolk and L. Sampson:
personal communications). We used the regression-residual
method (30) to adjust nutrient intakes for a total energy intake of
1600 kcal/day for women and 2100 kcal/day for men.
Among dietary covariates, there were no missing data for
nutrients. In most studies, less than 1% of the participants in
each study had missing values for intake of red meat and
alcohol.
Nondietary Covariates
Each study collected baseline information on nondietary co-
variates by using self-administered questionnaires. Most studies
assessed age, smoking habits, physical activity, education,
height, weight, multivitamin use, and, among women, oral con-
traceptive use and postmenopausal hormone use. The proportion
of missing values was generally less than 5% in each study that
measured the covariate. We categorized the covariate informa-
tion in a consistent manner across studies.
Statistical Analysis
Primary data for dairy food and calcium intakes were mod-
eled as categorical variables with uniform absolute intake cut
points across the studies. Intake cut points were chosen to ensure
a good number of cases in each category and to minimize
exclusion of individual studies from any of the intake categories.
Calcium intake was also categorized by study-specific quantiles
on the basis of the distributions of the subcohorts in the Cana-
dian National Breast Screening Study (23) and The Netherlands
Cohort Study (12), each of which used a case–cohort design (31)
and on the distributions of the whole cohort in the remaining
studies. To calculate the Ptrend, we assigned participants the
median value of their category of intake, and this variable was
used as a continuous variable in the study-specific regression
models.
Each study was analyzed with the Cox proportional hazards
model. The assumptions of proportionality were satisfied. Epi-
cure software (32) was used for the Canadian National Breast
Screening Study (23) and The Netherlands Cohort Study (12),
and SAS PROC PHREG (33) was used for the remaining stud-
ies. We stratified the data by age at baseline and by the year that
the baseline questionnaire was returned. Person-years of
follow-up were calculated from the date the questionnaire was
returned until the date of colorectal cancer diagnosis, death, or
end of follow-up, whichever came first. Multivariable relative
risks (RRs) were adjusted for smoking (never, past smoker with
20 years’ duration, past smoker with 20–39 years’ duration,
past smoker with 40 years’ duration, current smoker of 25
cigarettes per day and 40 years’ duration, current smoker of
25 cigarettes per day and 40 years’ duration, current smoker
of 25 cigarettes per day and 40 years’ duration, or current
smoker of 25 cigarettes per day and 40 years’ duration),
body mass index (23, 23 to 25, 25 to 30, or 30 kg/m2 of
body surface area), education (less than high school, high school
graduate, or more than high school), height (1.60, 1.60 to
1.65, 1.65 to 1.70, 1.70 to 1.75, or 1.75 m for women;
1.70, 1.70 to 1.75, 1.75 to 1.80, 1.80 to 1.85, or 1.85
m for men), physical activity (low, medium, or high), family
history of colorectal cancer (no, yes), use of nonsteroidal anti-
inflammatory drugs (no, yes), use of multivitamins [no, yes
6/week, yes 6/week, or yes missing dose for the Health
Professionals Follow-up Study (17), Iowa Women’s Health
Study (11), and Nurses’ Health Study (17); no, yes for the
Alpha-Tocopherol Beta-Carotene Cancer Prevention Study (16),
The Netherlands Cohort Study (12), and New York State Cohort
(24)], energy intake (continuous), alcohol intake (0, 0 to 5,
5 to 15, 15 to 30, 30 g/day), red meat (quartiles), and
dietary folate (quintiles). For women, the relative risks were also
adjusted for history of oral contraceptive use (no, yes) and
postmenopausal hormone use (premenopausal, ever, never). If
1016 ARTICLES Journal of the National Cancer Institute, Vol. 96, No. 13, July 7, 2004
there were missing data for a measured covariate within a study,
an indicator variable was created for missing responses for that
covariate. Two-sided 95% confidence intervals (CIs) were cal-
culated. A random-effects model was used to combine the study-
specific loge relative risks (34); the study-specific relative risks
were weighted by the inverse of their variance. Tests of heter-
ogeneity were conducted by using the Q statistic (34,35).
We evaluated whether total calcium intake was nonlinearly
associated with colorectal cancer by comparing the nonparamet-
ric regression curve using restricted cubic splines to the linear
Table 1. Characteristics of the cohort studies included in the pooled analysis of dairy foods and calcium intake and colorectal cancer
Study
Follow-up
period Sex*
Baseline
cohort
size
No.
of
cases
Mean (SD) intake of:
Milk†
(g/day)
Cheese‡
(g/day)
Yogurt§
(g/day)
Dietary
calcium
(mg/day)
Total
calcium
(mg/day)
Adventist Health Study 1976–1982 W 18 403 95 419 (349) 8 (8) — 833 (124) 880 (139)
M 12 896 74 436 (349) 9 (8) — 1051 (123) 1087 (136)
Alpha-Tocopherol Beta-Carotene Cancer Prevention Study 1985–1995 M 26 987 184 687 (385) 25 (28) 14 (37) 1049 (312) 1052 (314)
Canadian National Breast Screening Study 1980–1993 W 56 837 284 201 (203) 22 (24) 30 (63) 674 (255) —
Health Professionals Follow-up Study 1986–1996 M 47 673 408 219 (251) 11 (13) 20 (51) 836 (320) 931 (413)
Iowa Women’s Health Study 1986–1998 W 34 603 796 275 (266) 11 (13) 11 (38) 749 (286) 1031 (484)
The Netherlands Cohort Study 1986–1993 W 62 573 501 187 (153) 23 (18) 53 (57) 868 (259) —
M 58 279 646 199 (178) 23 (19) 42 (56) 928 (289) —
New York State Cohort 1980–1987 W 22 550 296 137 (87) — — 828 (209) 873 (220)
M 30 363 492 139 (85) — — 867 (223) 904 (233)
New York University Women’s Health Study 1985–1997 W 13 258 116 203 (241) 17 (22) 38 (61) 810 (306) —
Nurses’ Health Study (a) 1980–1986 W 88 651 220 215 (242) 14 (15) 22 (55) 723 (299) 732 (311)
Nurses’ Health Study (b) 1987–1996 W 68 540¶ 420 222 (230) 13 (13) 28 (55) 719 (254) 1068 (496)
Sweden Mammography Cohort 1987–1998 W 61 463 460 156 (130) 27 (19) 104 (108) 913 (255) —
Total 534 536 4992
*W  women; M  men.
†Milk included skim, low-fat, medium-fat, whole, evaporated, and butter milk. Values in parentheses are standard deviations (SD).
‡Cheese included high-fat, low-fat, hard, and other cheese. —  none.
§Yogurt included low-fat and regular yogurt and yogurt dressing.
Energy-adjusted values. Dietary calcium indicates calcium from food only. Total calcium indicates calcium from food and supplements.
¶These women are a subset of the women included in the Nurses’ Health Study (a) and are not included in the total.
Table 2. Pooled relative risks of colorectal cancer for categories of dairy food intake*
Cases and RRs
Intake category
(g/day) Ptrend
P, test for between-study
heterogeneity for top
category
P, test for between-study
heterogeneity due to sex
for top category
Milk†
70 70–174 175–249 250
No. of cancer cases 4946 1065 1360 1154
Age-adjusted RR (95% CI) 1.00 (referent) 0.94 (0.86 to 1.02) 0.87 (0.80 to 0.95) 0.84 (0.77 to 0.92) .001 .66 .85
Multivariate‡ RR (95% CI) 1.00 (referent) 0.94 (0.86 to 1.02) 0.88 (0.81 to 0.96) 0.85 (0.78 to 0.94) .001 .63 .49
Cheese, excluding cottage, ricotta, and cream cheese
5 5–13 14–24 25
No. of cancer cases 4146 1173 906 932
Age-adjusted RR (95% CI) 1.00 (referent) 1.05 (0.96 to 1.15) 1.09 (0.96 to 1.23) 1.12 (0.98 to 1.28) .13 .15 .20
Multivariate‡ RR (95% CI) 1.00 (referent) 1.03 (0.94 to 1.12) 1.06 (0.95 to 1.18) 1.10 (0.98 to 1.24) .21 .37 .18
Yogurt
0 1–24 25–74 75
No. of cancer cases 3837 687 485 725
Age-adjusted RR (95% CI) 1.00 (referent) 0.93 (0.84 to 1.02) 0.85 (0.72 to 1.01) 0.90 (0.81 to 0.99) .09 .82 .67
Multivariate‡ RR (95% CI) 1.00 (referent) 0.95 (0.86 to 1.04) 0.88 (0.74 to 1.04) 0.93 (0.83 to 1.03) .34 .72 .59
*RR  relative risk; CI  confidence interval. For context, the weight is 224 g for 8 oz of milk, 28 g for 1 oz of cheese, and 227 g for 1 cup of yogurt.
†The New York State Cohort was not included in the top category due to limited intake distribution.
‡Multivariable relative risks were adjusted for smoking (never, past smoker 20 years’ duration, past smoker 20–39 years’ duration, past smoker 40 years’
duration, current smoker 25 cigarettes per day and 40 years’ duration, current smoker 25 cigarettes per day and 40 years’ duration, current smoker 25
cigarettes per day and 40 years’ duration, or current smoker 25 cigarettes/day and 40 years’ duration), body mass index (23, 23 to 25, 25 to 30, or 30
kg/m2), education (less than high school, high school graduate, or more than high school), height (1.60, 1.60 to 1.65, 1.65 to 1.70, 1.70 to 1.75, or 1.75
m for women; 1.70, 1.70 to 1.75, 1.75 to 1.80, 1.80 to 1.85, or 1.85 m for men), physical activity (low, medium, or high), family history of colorectal
cancer (no, yes), use of nonsteroidal anti-inflammatory drugs (no, yes), use of multivitamins (no, yes 6/wk, yes 6/wk, or yes missing dose for the Health
Professionals Follow-up Study, Iowa Women’s Health Study, and Nurses’ Health Study (a) and (b); no, yes, for the Alpha-Tocopherol Beta-Carotene Cancer
Prevention Study, Netherlands Cohort Study, and New York State Cohort), energy intake (continuous), alcohol intake (0, 0–5, 5–15, 15–30, 30 g/day),
red meat (quartiles), and dietary folate (quintiles). For women, the relative risks were also adjusted for history of oral contraceptive use (no, yes) and postmenopausal
hormone use (premenopausal, ever, never).
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model using the likelihood ratio test and by visual inspection of
the graphs (36,37). Studies were combined into a single dataset
stratified by study for these analyses. Four knot positions were
specified at the 5th (406 mg/day), 35th (716 mg/day), 65th (997
mg/day), and 95th percentiles (1667 mg/day) for calcium intake
based on the intake distribution across all studies.
To evaluate heterogeneity, we tested for variation in relative
risks by sex and vitamin D intake by using meta-regression
models (38). We evaluated whether associations differed by
subsite of the large bowel (proximal colon, distal colon, and
rectum), using a Wald test (39,40) to test the null hypothesis of
no difference among the loge rate ratios.
RESULTS
During follow-up, which ranged from up to 6 to 16 years
across the 10 cohort studies, 4992 incident cases of colorectal
cancer were documented (Table 1). Milk intake was the lowest
(137 g/day) in the New York State Cohort and highest (687
g/day) in the Alpha-Tocopherol Beta-Carotene Cancer Preven-
tion Study. By contrast, yogurt consumption was the highest (53
g/day and 104 g/day) in The Netherlands Cohort Study and
Sweden Mammography Cohort, respectively, in which milk
intakes were low. On the other hand, in the Alpha-Tocopherol
Beta-Carotene Cancer Prevention Study and most of the U.S.
cohorts, more than 50% of the participants did not consume
yogurt.
Milk consumption was inversely related to colorectal cancer
risk (Table 2). Compared with participants who consumed less
than 70 g/day of milk, the pooled multivariate relative risks for
colorectal cancer were 0.94 (95% CI  0.86 to 1.02) for those
who consumed 70–174 g/day, 0.88 (95% CI  0.81 to 0.96) for
those who consumed 175–249 g/day, and 0.85 (95% CI  0.78
to 0.94) for those who consumed 250 g/day or more (test for
between-study heterogeneity, P .63; Ptrend.001). The inverse
associations with milk consumption were similar in women and
men; the pooled multivariable relative risks for participants who
consumed 250 g/day or more of milk compared with participants
who consumed less than 70 g/day were 0.84 (95% CI  0.75 to
0.94) for women (n  3188) and 0.90 (95% CI  0.74 to 1.10)
for men (n  1804) (test for between-study heterogeneity due to
sex, P  .49). Each 500-g/day (approximately two 8-oz glasses)
increase in milk consumption was associated with a 12% re-
duced risk of colorectal cancer (Fig. 1). The inverse association
for milk consumption was highly consistent across studies (test
for between-study heterogeneity, P  .64). Cheese intake was
weakly positively associated and yogurt intake was weakly
inversely associated with colorectal cancer risk, but trends for
neither were statistically significant (Table 2).
We also examined colorectal cancer risk associations with
intake of other dairy foods, including cottage or ricotta cheese,
butter, cream, and ice cream, which were measured in at least
five studies. Participants who consumed more than 25 g/day
(highest intake category) of cottage or ricotta cheese had an RR
of 0.83 (95% CI  0.72 to 0.96) compared with those who did
not consume cottage or ricotta cheese (lowest intake category).
Other dairy foods were not statistically significantly related to a
reduced risk of colorectal cancer (data not shown). The associ-
ation with fermented dairy fluid products, which include yogurt,
buttermilk, and sour cream, was similar to that of yogurt; the
relative risk for participants who consumed the most compared
with those who consumed the least was 0.91 (95% CI  0.82 to
1.00).
Because the association between dairy foods and colorectal
cancer risk may vary by cancer site, we analyzed associations for
cancers of the colon (proximal and distal colon) and rectum
separately (Table 3). The associations for milk consumption
varied by cancer site (test for common effects by cancer site,
P  .03), and the inverse association was limited to cancers of
the distal colon and rectum. The associations between cheese or
yogurt consumption and colorectal cancer risk were not statis-
tically significantly different across the cancer site of the large
bowel.
High intakes of dietary and total calcium (i.e., from diet and
supplements) were associated with a lower risk of colorectal
cancer (Table 4). When we limited the analysis of dietary
calcium to the subset of studies with total calcium intake, the
results were similar to those shown in Table 4 (data not shown).
To examine more extreme contrasts, we compared the top
and bottom deciles of calcium intake. The RRs for colorectal
cancer were 0.79 (95% CI  0.67 to 0.88; Ptrend  .004) for
dietary calcium and 0.70 (95% CI  0.59 to 0.83; Ptrend.001)
for total calcium intake. When we evaluated absolute intake
categories of calcium intake across studies, the results were
consistent with those from quantile analyses. Compared with
participants with an intake of less than 500 mg/day (referent),
Fig. 1. Study-specific and pooled multivariable relative risks of colorectal cancer
for each 500-g/day (approximately two 8-oz glasses) increase in milk intake. The
black squares and horizontal lines correspond to the study-specific relative
risks and 95% confidence intervals for a 500-g/day increase in milk intake. The
area of the black squares reflects the study-specific weight (inverse of the
variance), which is related to sample size and intake variation. The diamond
represents the pooled multivariable relative risk and 95% confidence interval.
The dashed line represents the pooled multivariable relative risk. Studies that
included data on both sexes were considered as individual cohorts and are
designated by F (female) and M (male), respectively. AHS  Adventist Health
Study; ATBC  Alpha-Tocopherol Beta-Carotene Cancer Prevention Study;
CNBSS  Canadian National Breast Screening Study; HPFS  Health Profes-
sionals Follow-up Study; IWHS  Iowa Women’s Health Study; NLCS 
Netherlands Cohort Study; NYSC New York State Cohort; NYUWHS New
York University Women’s Health Study; NHSa  Nurses Health Study (a);
NHSb  Nurses Health Study (b); SMC  Sweden Mammography Cohort.
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the RRs were 0.90 (95% CI  0.73 to 1.11) for those with an
intake of 500 –599 mg/day, 0.83 (95% CI  0.66 to 1.05) for
those with an intake of 600 – 699 mg/day, 0.79 (95% CI 
0.67 to 0.94) for those with an intake of 700 –799 mg/day,
0.89 (95% CI  0.74 to 1.06) for those with an intake of
800 – 899 mg/day, 0.79 (95% CI  0.67 to 0.93) for those
with an intake of 900 –1099 mg/day, 0.76 (95% CI  0.64 to
0.91) for those with an intake of 1100 –1299 mg/day, and 0.74
(95% CI  0.62 to 0.88) for those with an intake of 1300
mg/day or more (Ptrend.001). In nonparametric regression
analyses, the plot was also suggestive of a threshold effect of
total calcium intake, with little further reduction in the risk of
colorectal cancer with calcium intakes of more than approx-
imately 1000 mg/day (Fig. 2).
Additional adjustment for total vitamin E, total fat, and di-
etary fiber intake did not materially change the results for total
calcium intake (data not shown). For dietary calcium and total
calcium, the pattern of the associations by colorectal cancer
disease location was similar to that observed for milk intake.
Because dairy foods are a good source of vitamin D, which
has been hypothesized to reduce colorectal cancer risk (41), we
examined the independent effects of calcium and vitamin D
intakes in the five studies with total vitamin D intake data (n 
2816 colorectal cancer cases). Spearman correlation coefficients
for total calcium and total vitamin D were generally more than
0.5 across studies. In analyses in which both nutrients were
included in the multivariable models, the relative risk for the
highest quintile of total calcium intake compared with the lowest
changed slightly but was still statistically significant (from 0.78
[95% CI  0.69 to 0.88] to 0.83 [95% CI  0.72 to 0.95]), and
the corresponding relative risk for total vitamin D changed from
0.86 (95% CI  0.73 to 1.01) to 0.93 (95% CI  0.79 to 1.10)
after the adjustment. Table 5 presents the results for total cal-
cium intake by tertiles of total vitamin D intake. Although the
Table 3. Pooled multivariable relative risks (95% confidence interval) by cancer site of colorectal cancer according to dairy food intake*
Cancer site
Intake category
(g/day) Ptrend
P, test for
between-study
heterogeneity
for top
category
P, test for
between-study
heterogeneity
due to sex for
top category
P, test for common
effects by cancer
site (proximal
colon, distal colon,
and rectum) for top
category
Milk†
70 70–174 175–249 250
Colon (n  3482) 1.00 (referent) 0.94 (0.85 to 1.04) 0.88 (0.80 to 0.97) 0.88 (0.79 to 0.99) .01 .76 .80
Proximal (n  1732) 1.00 (referent) 1.00 (0.87 to 1.16) 0.91 (0.79 to 1.06) 0.99 (0.85 to 1.15) .56 .79 .65
Distal (n  1471) 1.00 (referent) 0.89 (0.76 to 1.04) 0.85 (0.73 to 0.98) 0.73 (0.62 to 0.87) .001 .99 .64
Rectal (n  1437) 1.00 (referent) 0.94 (0.77 to 1.15) 0.89 (0.76 to 1.05) 0.80 (0.66 to 0.96) .02 .34 .36 .03
Cheese, excluding cottage, ricotta, and cream cheese
5 5–13 14–24 25
Colon (n  2912) 1.00 (referent) 1.03 (0.92 to 1.16) 1.02 (0.86 to 1.22) 1.14 (0.95 to 1.36) .38 .10 .30
Proximal (n  1505) 1.00 (referent) 1.05 (0.91 to 1.20) 0.93 (0.77 to 1.12) 1.21 (1.00 to 1.45) .20 .78 .46
Distal (n  1238) 1.00 (referent) 1.00 (0.84 to 1.20) 1.11 (0.88 to 1.39) 1.03 (0.84 to 1.26) .94 .61 .60
Rectal (n  1208) 1.00 (referent) 1.06 (0.90 to 1.26) 1.19 (0.98 to 1.44) 1.08 (0.86 to 1.36) .28 .31 .47 .47
Yogurt
0 1–24 25–74 75
Colon (n  2724) 1.00 (referent) 0.98 (0.88 to 1.09) 0.86 (0.75 to 1.00) 0.89 (0.78 to 1.01) .22 .76 .71
Proximal (n  1396) 1.00 (referent) 0.96 (0.82 to 1.12) 0.76 (0.60 to 0.96) 0.85 (0.68 to 1.06) .13 .18 .84
Distal (n  1166) 1.00 (referent) 1.05 (0.89 to 1.24) 1.03 (0.84 to 1.27) 0.93 (0.76 to 1.14) .64 .75 .74
Rectal (n  1129) 1.00 (referent) 0.88 (0.73 to 1.00) 0.98 (0.72 to 1.33) 1.03 (0.86 to 1.25) .73 .75 .23 .41
*The relative risks were adjusted for the same covariates as the multivariate model in Table 2. Colon cancers were considered to be those from the cecum through
the sigmoid colon. Tumors from the cecum to the splenic flexure were considered to be proximal colon cancers, and the remaining tumors in the colon were defined
as distal colon cancers. Rectal cancers included tumors in the rectum and the rectosigmoid junction.
†The New York State Cohort was not included in the top category due to limited intake distribution.
Table 4. Pooled relative risks and 95% confidence intervals of colorectal cancer according to energy-adjusted calcium intake
Cases and RRs
Intake quintile
Ptrend
P, test for
between-study
heterogeneity
for quintile 5
P, test for
between-study
heterogeneity
due to sex for
quintile 51 (low) 2 3 4 5 (high)
Dietary calcium
No. of cancer cases 1062 999 978 1007 946
Age-adjusted RR (95% CI) 1.00 (referent) 0.93 (0.83 to 1.04) 0.89 (0.81 to 0.97) 0.90 (0.81 to 1.01) 0.83 (0.76 to 0.91) .001 .92 .36
Multivariate* RR (95% CI) 1.00 (referent) 0.94 (0.84 to 1.05) 0.91 (0.83 to 0.99) 0.93 (0.83 to 1.04) 0.86 (0.78 to 0.95) .02 .98 .66
Total calcium
No. of cancer cases 665 589 627 552 552
Age-adjusted RR (95% CI) 1.00 (referent) 0.86 (0.77 to 0.97) 0.88 (0.79 to 0.99) 0.76 (0.68 to 0.85) 0.74 (0.64 to 0.83) .001 .98 .72
Multivariate† RR (95% CI) 1.00 (referent) 0.87 (0.78 to 0.97) 0.90 (0.80 to 1.01) 0.79 (0.70 to 0.88) 0.78 (0.69 to 0.88) .001 .97 .83
*The relative risks were adjusted for the same covariates as the multivariable model in Table 2. RR  relative risk; CI  confidence interval.
†The relative risks were adjusted for the same covariates except multivitamin use as the multivariable model in Table 2.
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test for heterogeneity for the highest quintile of total calcium
intake across tertiles of total vitamin D intake was not statisti-
cally significant (P  .29), total calcium intake was statistically
significantly inversely associated with colorectal cancer risk
only within the highest tertile of total vitamin D intake. We also
examined the cross-classifications of these nutrients modeled as
tertiles. The relative risk was the lowest (RR  0.74, 95% CI 
0.65 to 0.84) for persons in the highest tertiles of both total
calcium and total vitamin D intake compared with the lowest
tertile of intake for both nutrients.
We also examined associations with milk, calcium, and vita-
min D intakes when all three dietary factors were included in the
model simultaneously among the five studies that measured all
three dietary factors (Spearman correlation coefficients between
milk and total calcium intake ranged from 0.38 to 0.78 across
studies and between milk and total vitamin D intake were
generally more than 0.3 across studies). The multivariate relative
risk for the highest category of milk intake (250 g/day) was
attenuated from 0.80 (95% CI  0.70 to 0.91) to 0.84 (95% CI
 0.71 to 1.00) after simultaneous adjustment for total calcium
and total vitamin D intakes. The relative risk for the highest
quintile of total calcium was attenuated from 0.78 (95% CI 
0.69 to 0.88) to 0.90 (95% CI  0.77 to 1.05). The highest
quintile of total vitamin D was attenuated from 0.86 (95% CI 
0.74 to 1.01) to 0.96 (95% CI  0.81 to 1.14).
To calculate the population attributable risk for calcium in-
take for women and men separately, we combined studies of the
same sex into a single dataset and used the age-adjusted relative
risk and prevalence of calcium intakes of less than 1000 mg/day
(76% of women and 58% of men). Assuming that the association
between calcium and colorectal cancer risk is causal, if individ-
uals who consumed less than 1000 mg/day of calcium increased
their intake to 1000 mg/day or more, 15% and 10% of the
colorectal cancer cases in this study population would have been
avoided for women and for men, respectively.
DISCUSSION
In these pooled analyses of prospective studies, we found that
milk and calcium intakes were related to a lower risk of colo-
rectal cancer. The inverse associations were consistent across
studies and sex.
A growing body of evidence indicates that calcium prevents
colorectal carcinogenesis by influencing a complex series of
signaling events induced at various tiers of colonic cell organi-
zation (42). Several animal studies (3) and some (4,6,43–45),
but not all (46–49), clinical trials have shown that consumption
of calcium and dairy food reduced colonic epithelial cell prolif-
eration. Clinical trials also have suggested that calcium intake
reduced the recurrence of colorectal adenomas (5,50). However,
none of these trials directly evaluated the effects of dairy foods
or calcium on colorectal cancer risk.
Many epidemiologic studies have examined consumption of
dairy foods and/or calcium and colorectal cancer risk, but their
findings have been inconclusive. A meta-analysis of the pub-
lished literature (10), which included a few of the studies in the
current analyses, found an inverse association with milk intake
for cohort studies (RR  0.80 [95% CI  0.68 to 0.95; P
heterogeneity  .77] for high versus low intake) but not for
case–control studies. The analysis found no clear association
between cheese or yogurt intake and colorectal cancer, consis-
tent with our findings. The meta-analysis did not provide data on
the dose–response relationship of dairy food intake and colorec-
tal cancer risk because published data with different intake cut
points across studies were combined. For calcium intake and
colorectal cancer risk, a meta-analysis of 24 studies (eight cohort
and 16 case–control studies) (8), which included some of the
studies in the current analysis, reported an RR of 0.86 (95% CI
 0.74 to 0.98) for individuals in the highest category of calcium
intake compared with individuals in the lowest category. There
was significant heterogeneity across the studies, whereas we
found no suggestion of heterogeneity among the cohort studies
included in our analysis for calcium or any of the dairy products
examined.
Among the dairy items we examined, only milk consumption
was statistically significantly associated with a lower risk of
Fig. 2. Nonparametric regression curve for the relationship between total cal-
cium intake and colorectal cancer. We excluded participants in the top 1% of
total calcium intakes in each study to avoid excessive influence of extreme
intakes and treated the studies as a single data set.
Table 5. Pooled multivariable relative risks for total calcium intake by levels of total vitamin D Intake*
Tertile of total
vitamin D
intake
Quintile of total calcium intake
Ptrend
P, test for
between-study
heterogeneity
for quintile 5
P, test for
between-study
heterogeneity
due to sex for
quintile 51 (low) 2 3 4 5 (high)
1 (n  1001) 1.00 (referent) 0.88 (0.75 to 1.03) 1.04 (0.86 to 1.25) 0.73 (0.52 to 1.01) 0.87 (0.64 to 1.18) .08 .70 .17
2 (n  954) 1.00 (referent) 1.00 (0.77 to 1.30) 0.88 (0.66 to 1.19) 0.87 (0.67 to 1.13) 0.96 (0.73 to 1.26) .88 .42 .84
3 (n  861) 1.00 (referent) 0.77 (0.58 to 1.02) 0.79 (0.60 to 1.03) 0.70 (0.54 to 0.91) 0.72 (0.55 to 0.92) .04 .78 .29
*The relative risks were adjusted for the same covariates except multivitamin use as the multivariable model in Table 2. P, test for heterogeneity for quintile 5
of total calcium intake across tertiles of total vitamin D intake was .29.
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colorectal cancer, although the results for most of the other dairy
foods were suggestive of inverse associations. This difference
may have occurred because milk had a wider intake distribution
than that of other dairy products. Another explanation: U.S.-
based national surveys have reported that milk is the most
important contributor to dietary calcium intake (51).
Calcium intake was inversely associated with the risk of
colorectal cancer, with the inverse association being statistically
significant only among those in the highest vitamin D intake
category, although the difference in associations across vitamin
D intake levels was not statistically significant. In addition, in a
cross-classified analysis, the inverse association was strongest
for the highest versus the lowest intakes of both nutrients to-
gether, possibly because vitamin D enhances calcium absorption
and vitamin D itself may decrease colorectal cancer incidence
(52). In our analyses, we could not distinguish clearly between
the effects of milk and calcium because of their strong correla-
tion in most studies. Calcium in milk is highly bioavailable,
which may make milk appear to be associated with colorectal
cancer risk independent of total calcium intake. Also, other
components in milk may contribute to the inverse association.
Dairy foods contain conjugated linoleic acid and lactoferrin,
which inhibit colonic carcinogenesis in animal models (53,54),
and the milk protein casein has antimutagenic activity on the
digestive tract (55). Certain microorganisms in fermented dairy
foods have also been hypothesized to reduce the risk of colo-
rectal cancer (12). In our study, fermented food products such as
yogurt or cheese, or fermented dairy fluids as a whole, were not
strongly associated with colorectal cancer risk, but we had a
limited ability to detect an association because the consumption
of these foods was relatively low in most of the cohort studies.
Some of the etiologic factors for cancers of the proximal and
distal colon may differ (56,57). Cancers of the distal colon have
been hypothesized to be more related to exogenous factors such
as diet than cancers of the proximal colon (56,57). We found that
the inverse association between milk intake and colorectal can-
cer risk was limited to cancers of the distal colon and rectum,
which is consistent with results of some of the previous studies
(58–60) but not others (61).
Our study has several strengths. By including only prospec-
tive cohort studies that used validated diet assessment instru-
ments, we minimized the possibility of bias and misclassifica-
tion. Furthermore, by examining the primary data instead of the
published literature and applying uniform criteria to define the
food and nutrient variables and other covariates, if available, we
minimized potential sources of heterogeneity and improved
comparability of the results across the studies. We were able to
evaluate the associations across several populations with differ-
ent dietary intake patterns and confirmed that the results were
consistent across these studies. We examined calcium intake as
study-specific quantiles as well as categories based on identical
absolute intake cut points. Analyses using study-specific quan-
tiles rank and classify participants using identical methods
across studies and ensure that there are enough cases in each
category. However, if distributions of intake across the studies
are different, each quantile may not be comparable across stud-
ies. Analyses using identical absolute intake cut points take
advantage of the actual range of intakes but assume that the
intakes are measured comparably across studies. Despite these
different analytic approaches and different sources of potential
misclassification, we found that the results for these two ap-
proaches were consistent. Because information on calcium sup-
plements was available in only four of the studies and the
amount of calcium in multivitamins is usually small, we had
limited ability to examine very high calcium intakes.
In summary, in this pooled analysis of 10 prospective studies,
we found that increased consumption of milk and calcium were
related to a lower risk of colorectal cancer. These data, in
combination with the previous experimental studies document-
ing a salutary effect of calcium supplementation on colonic
epithelial cell turnover and colorectal adenoma recurrence, sup-
port the concept that moderate milk and calcium intake reduces
the risk of colorectal cancer.
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